Single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma.

Lancet Haematol

Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicadas (Cima), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBERONC, Pamplona, Spain.

Published: October 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(23)00278-8DOI Listing

Publication Analysis

Top Keywords

single-agent belantamab
4
belantamab mafodotin
4
mafodotin patients
4
patients relapsed
4
relapsed refractory
4
refractory multiple
4
multiple myeloma
4
single-agent
1
mafodotin
1
patients
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!